Cardiac sarcoidosis: a diagnostic and therapeutic challenge

Area of Science:

• Cardiology
• Immunology
• Internal Medicine

Background:

• Cardiac involvement in sarcoidosis presents diverse clinical signs, with atrioventricular block and ventricular arrhythmias being most common.
• Diagnosis of cardiac sarcoidosis is often difficult due to initial non-specific findings.
• Limited data exist to guide treatment decisions for rare cardiac manifestations of this systemic disorder.

Purpose of the Study:

• To review current understanding and identify gaps in the diagnosis and treatment of cardiac sarcoidosis.
• To highlight the need for improved diagnostic and risk stratification methods.
• To underscore areas of ongoing debate in management strategies.

Main Methods:

• Comprehensive review of current guidelines.
• Analysis of existing cohort studies.
• Synthesis of expert opinions on diagnosis and treatment.

Main Results:

• Cardiac sarcoidosis diagnosis is challenging due to varied presentations and non-specific initial findings.
• Current data are insufficient to definitively guide treatment decisions.
• Key aspects of management, including steroid dosage, ICD implantation, and ablation techniques, remain subjects of debate.

Conclusions:

• Longitudinal follow-up studies are essential for enhancing diagnostic accuracy and risk stratification in cardiac sarcoidosis.
• Optimal treatment strategies, including steroid therapy, indications for internal cardioverter-defibrillators (ICDs), and ablation procedures, require further investigation and consensus.
• There is a critical need for evidence-based research to improve patient outcomes in cardiac sarcoidosis.